Marcovici I, Brill A I, Scommegna A
Department of Obstetrics and Gynecology, University of Illinois, Chicago.
Obstet Gynecol. 1993 Jan;81(1):118-21.
To determine whether colchicine, an anti-inflammatory drug, is effective in reducing adhesion formation in a rabbit model in which pelvic inflammation was produced by injection of a suspension of Neisseria gonorrhoeae into the uterine horn.
Following inoculation, the rabbits were divided into four groups of 11 animals each. The control group received 1 mL saline intramuscularly (IM) for 14 days. Another group received one 100-mg dose of ceftriaxone IM 2-4 hours after inoculation. The third group received one 100-mg dose of ceftriaxone IM 2-4 hours after inoculation and 1 mg colchicine IM daily for 14 days. The fourth group received 1 mg colchicine IM daily for 14 days. The day after the last injection of colchicine, the rabbits were sacrificed and the abdominal cavities were explored to determine the number and grade of adhesions.
The incidence of adhesions in the control group was similar to that in the antibiotic-treated group, suggesting that antibiotics do not prevent adhesions in this model. Similarly, the incidence of adhesions in the colchicine and antibiotic group was not different from that in the group receiving colchicine alone. However, the colchicine-treated groups had significantly fewer adhesions than the groups not treated with colchicine (P < .0005).
In this model, antibiotics alone did not prevent the formation of adhesions. Colchicine, alone or in combination with antibiotics, was effective in preventing bacteria-induced pelvic adhesions. Therefore, colchicine may offer a novel approach to the prevention of adhesions associated with pelvic inflammatory disease in women.
确定抗炎药物秋水仙碱在通过向兔子宫角注射淋病奈瑟菌悬液造成盆腔炎症的兔模型中,对减少粘连形成是否有效。
接种后,将兔子分为四组,每组11只。对照组肌肉注射(IM)1毫升生理盐水,共14天。另一组在接种后2 - 4小时肌肉注射一剂100毫克头孢曲松。第三组在接种后2 - 4小时肌肉注射一剂100毫克头孢曲松,并每天肌肉注射1毫克秋水仙碱,共14天。第四组每天肌肉注射1毫克秋水仙碱,共14天。在最后一次注射秋水仙碱后的第二天,处死兔子并探查腹腔,以确定粘连的数量和等级。
对照组粘连的发生率与抗生素治疗组相似,表明在该模型中抗生素不能预防粘连。同样,秋水仙碱与抗生素联合组粘连的发生率与仅接受秋水仙碱组无差异。然而,秋水仙碱治疗组的粘连明显少于未用秋水仙碱治疗的组(P < .0005)。
在该模型中,单独使用抗生素不能预防粘连形成。秋水仙碱单独或与抗生素联合使用,对预防细菌诱导的盆腔粘连有效。因此,秋水仙碱可能为预防女性盆腔炎相关粘连提供一种新方法。